GlobeNewswire

Global recognition highlights Caseware’s AI-powered platform and innovation in automating audit and accounting workflows Ericka Podesta McCoy, Chief Marketing Officer,…

ATLANTA, March 19, 2026 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Gemini Space Station, Inc.…

Washington, D.C., March 19, 2026 (GLOBE NEWSWIRE) — His Majesty King Willem-Alexander and Her Majesty Queen Máxima will pay a…

A Media Snippet accompanying this announcement is available by clicking on this link. LODZ, Poland, March 19, 2026 (GLOBE NEWSWIRE)…

Recognition highlights SnapLogic’s strength in low-code AI agent development and enterprise-scale orchestration San Mateo, California, March 19, 2026 (GLOBE NEWSWIRE)…

Los Angeles-based luxury modular sofa brand opens largest showrooms to date, and deepens Texas investment 7th Avenue Austin Interior Showroom…

Serstech has today received a frame order from its partner Anton Paar with a total value of 5.3 MSEK. The…

Cannes, France, March 19, 2026 (GLOBE NEWSWIRE) — Rayls will host its second hackathon during EthCC Cannes, bringing developers together…

Invite-only gathering brings together growth companies, investors, and industry leaders in Dana Point, California, from March 22-24, 2026 LOS ANGELES,…

Advancements in NGS, AI-driven bioinformatics, and expanding precision medicine initiatives are positioning genomics as a strategic pillar in modern healthcare,…

A new approach combines first-party data, verified engagement signals, and human validation to help marketers attract decision-makers and convert events…

Findings from Spherix Global Insights’ research reveal nearly three-quarters anticipate frontline use, with significant near-term share gains expected in second-line…

DUBAI, United Arab Emirates, March 19, 2026 (GLOBE NEWSWIRE) — Mutuum Finance is gaining visibility in crypto news today as…

Record quarter caps fiscal year of major product innovation, expansion, and market momentum strengthened by growing enterprise demand and Valimail…

Preliminary Phase 1 Study Results Show Strong Anti-Tumor Activity and Favorable Safety Profile for First-in-Class Small Molecule MYB mRNA Degrader…